lobbying_activities: 1107815

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1107815	a547479b-17ce-4ddd-9bf0-a6a99a7eea03	Q2	PARRY, ROMANI, DECONCINI & SYMMS	30792	MEDICIS PHARMACEUTICAL CORPORATION	2011	second_quarter	CPT	Oppose bills that prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. No specific legislation introduced yet.	SENATE	15000		0	0	2011-07-06T15:53:14.527000-04:00